Search results
Showing 2986 to 3000 of 7690 results
Charging procedure: technology appraisal and highly specialised technologies evaluations
Introduction In accordance with UK Statutory Instrument 2018 No.1322 , NICE must recover its costs for producing Technology Appraisals (TA) or Highly
Using our guidelines to help people make decisions about their care
Friday 22 July at 1:30pm via Zoom. Agenda Apologies for absence To receive any apologies for absence. Declarations of interest To declare
This indicator covers the contractor establishing and maintaining a register of patients with atrial fibrillation, including patients with ‘AF resolved’. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM164
Technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS. Browse technology...
NICE transparency of spend
Our publication scheme lists all of the information we routinely make available, and where you can find it. We publish most of the information below...
Highly specialised technologies evaluation committee members
Highly specialised technologies evaluation committee members
The different types of health, public health and social care information provided by NICE.
The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals. Read the appeal panel
The NICE real-world evidence framework aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence
Show all sections
- Overview
- Introduction to real-world evidence in NICE decision making
- Conduct of quantitative real-world evidence studies
- Assessing data suitability
- Methods for real-world studies of comparative effects
- Appendix 1 - Data Suitability Assessment Tool (DataSAT)
- Appendix 2 - Reporting on methods used to minimise risk of bias
- Appendix 3 - Reporting information for selected analytical methods
We work with an independent indicator advisory committee (IAC) to develop indicators suitable for inclusion in the Quality and Outcomes Framework...
Find out more about the progress made in implementing NICE guidance on diagnostic pathology
How we collect and use your personal information, and your rights under data protection legislation
Join Nice's Public Involvement Programme expert panel